Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024 Apr 17, 2024
No wonder ENTA dropped yesterday and today. It is a reminder that EDP-235 still hasn't moved into phase 3 despite excellent data in phase 2, either via partnership or funded by ENTA.